Lon Cardon, Ph.D., FMedSci
Board Member
Mirum Pharmaceuticals, Inc. (MIRM)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Lon Cardon, Ph.D., FMedSci
Lon Cardon, Ph.D., FMedSci is recorded as Board Member at Mirum Pharmaceuticals, Inc. (MIRM). Mirum Pharmaceuticals, Inc. reported in an 8-K filed December 19, 2022 that Lon Cardon, Ph.D., FMedSci was appointed Class I director, effective December 19, 2022.
“On December 19, 2022, the Board, upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Lon Cardon, Ph.D., FMedSci, to the Board, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-12-19–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Mirum Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Christopher Peetz CEO
- Michael Grey CEO
- Eric Bjerkholt CFO
- Peter Radovich COO
- Saira Ramasastry Board Member
- Timothy Walbert Board Member
- To approve Board Member
- William Fairey Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.